James R. Garvin

CytoBioscience, who creates and manufactures devices used in human cell research, as well as does its contract research, focused on new therapeutic drug development and has a world-renowned scientific and technical staff, collaborative partnerships with leading pharmaceutical companies and strategic alliances with key groups and academicinstitutions and its technology is used exclusively by the FDA in its safety pharmacology work. The technology also helps to reduce the cost of drug development as well as save valuable time in the development effort.